Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from LABORATORIO REIG JOFRE ( (ES:RJF) ) is now available.
Reig Jofre announced the execution of a free capital increase, allowing shareholders to receive preferential subscription rights. Shareholders can choose to exchange these rights for new shares, sell them for cash to the company or on the market, or combine these options, with the trading period for these rights set from May 15 to 29, 2025.
More about LABORATORIO REIG JOFRE
Laboratorio Reig Jofre is a company operating in the pharmaceutical industry, focusing on the development, manufacture, and marketing of pharmaceutical products. It is known for providing a range of health solutions, including prescription medicines and consumer healthcare products.
Average Trading Volume: 36,430
Technical Sentiment Signal: Buy
Current Market Cap: €242.7M
See more insights into RJF stock on TipRanks’ Stock Analysis page.